20
Rising Pharma Holdings Inc, based in Italy, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.
One of their notable products is METAXALONE, with a corresponding US DMF Number 15087.
Remarkably, this DMF maintains an Active status since its submission on October 11, 2000, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of February 26, 2013, and payment made on February 04, 2013, indicating their dedication to facilitating drug approvals, Categorized as Type II